剪接因子USP39促进卵巢癌恶性行为的作用及机制
批准号:
81672578
项目类别:
面上项目
资助金额:
50.0 万元
负责人:
刘招舰
依托单位:
学科分类:
肿瘤遗传与进化
结题年份:
2020
批准年份:
2016
项目状态:
已结题
项目参与者:
李鹏、张锡宇、李英伟、许立美、王玉琼、李杰银、张再新
中文摘要
选择性剪接是基因表达的重要调控机制,RNA-seq等分析发现95%以上的人类基因发生选择性剪接。肿瘤相关基因的异常剪接与肿瘤的发生和转移密切相关,而剪接因子的异常表达是导致肿瘤相关基因发生异常剪接的主要原因。我们前期研究发现剪接因子USP39在高级别浆液性卵巢癌组织中高表达并与预后相关,初步功能实验显示USP39促进卵巢癌细胞的克隆形成和侵袭力,选择性剪接表达谱分析发现了USP39的数个候选靶基因。本课题拟通过体内外实验系统研究USP39对卵巢癌细胞的增殖、侵袭及转移等恶性生物学行为的影响;利用小基因模型(mini-gene)、Northern blot、CLIP-Seq及体外剪接实验等方法筛选和鉴定USP39下游关键分子;利用临床组织标本,通过免疫组化方法分析USP39及下游分子的表达情况,以明确其与肿瘤发生发展及临床预后的相关性,为该病的诊断和治疗提供新的分子靶标。
英文摘要
Alternative splicing (AS) is an important process during gene expression regulation. To date, more than 90% of human precursor messenger RNAs (pre-mRNAs) are reported to undergo AS based on RNA-seq and EST analysis. The immense majority of genes are alternatively spliced and there are many isoforms specifically associated with cancer metastasis, angiogenesis and immune escape, etc. Several studies have demonstrated specific alterations in the expression of splicing factors in cancer. This may cause alternative splicing patterns in cancer. . Our previous study showed that USP39, a component of the U4/U6-U5 tri-snRNP, was overexpressed in high grade serous ovarian carcinoma (HGSOC) and was associated with poor prognosis. Pilot studies showed that USP39 overexpression promotes colony formation and cell invasion of ovarian cancer cells. Global profiling of alternative splicing in USP39 knockdown ovarian cancer cells showed a lot of changes of alternative spliced events. We also validated some candidate downstream target genes for USP39 by QPCR and western blot. All these preliminary findings prompt us to propose that USP39 may play an important role in the tumorigenesis and metastasis of HGSOC.. To test our hypothesis, we will first determine the effect of USP39 on tumorigenesis and metastasis of ovarian cancer in vitro and in vivo. Then, mini gene, northern blot, CLIP-seq and in vitro splicing assays will be used to identify downstream targets of USP39. Finally, we will examine the expressions of USP39 and its targets in HGSOC patient samples to determine whether their expressions are correlated with tumor progression and overall survival. The ultimate goal of this study is to clarify and characterize the functional role of USP39 in tumorigenesis and metastasis of HGSOC.
选择性剪接是基因表达中的重要调控机制。肿瘤相关基因的异常剪接与肿瘤的转移、血管新生及免疫逃逸等密切相关,而剪接因子的异常表达是导致肿瘤相关基因发生异常剪接的主要原因。本课题发现剪接因子USP39在高级别浆液性卵巢癌中高表达并与患者预后差密切相关;进一步研究发现USP39促进卵巢癌细胞的增殖、侵袭等恶性生物学行为;利用Rip- Seq结合RNA-seq方法分析发现USP39敲低细胞的剪接效率降低,并发现了包括HMGA2在内的数个靶基因。本课题圆满完成任务书规定研究目标。在该课题的资助下发表SCI论文5篇,其中4篇是第一标注,1篇是第二标注,另有1篇文章发表在Cell death &differ, 中科院1区,影响因子10.5。另外,授权1项国家发明专利,公开1项发明专利。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer
剪接体相关因子 CTNNBL1 促进卵巢癌的增殖和侵袭
DOI:
10.1016/j.yexcr.2017.05.008
发表时间:
2017-08-01
期刊:
EXPERIMENTAL CELL RESEARCH
影响因子:
3.7
作者:
[Li, Yingwei, Guo, Haiyang, Kong, Beihua]
通讯作者:
Kong, Beihua
miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma
miR-130a 在高级别浆液性卵巢癌中通过靶向 TSC1 上调 mTOR 通路并被 NF-κ B 反式激活
DOI:
10.1038/cdd.2017.129
发表时间:
2017-12-01
期刊:
CELL DEATH AND DIFFERENTIATION
影响因子:
12.4
作者:
[Wang, Yuqiong, Zhang, Xiyu, Liu, Zhaojian]
通讯作者:
Liu, Zhaojian
Cyclin F and KIF20A, FOXM1 target genes, increase proliferation and invasion of ovarian cancer cells
Cyclin F和KIF20A、FOXM1靶基因,增加卵巢癌细胞的增殖和侵袭
DOI:
10.1016/j.yexcr.2020.112212
发表时间:
2020-10-15
期刊:
EXPERIMENTAL CELL RESEARCH
影响因子:
3.7
作者:
[Li, Yingwei, Guo, Haiyang, Kong, Beihua]
通讯作者:
Kong, Beihua
Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma.
CD47 的过表达预示着高级别浆液性卵巢癌的不良预后并促进癌细胞侵袭。
DOI:
--
发表时间:
2017
期刊:
American Journal of Translational Research
影响因子:
2.2
作者:
[Li Yinuo, Lu Shuhua, Xu Ying, Qiu Chunping, Jin Chengjuan, Wang Yuqiong, Liu Zhaojian, Kong Beihua]
通讯作者:
Kong Beihua
MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2
MYC调节的假基因HMGA1P6通过增强致癌HMGA1/2促进卵巢癌恶性肿瘤
DOI:
10.1038/s41419-020-2356-9
发表时间:
2020-03-03
期刊:
CELL DEATH & DISEASE
影响因子:
9
作者:
[Tian, Xiaoxue, Song, Jianping, Liu, Zhaojian]
通讯作者:
Liu, Zhaojian
ADAR1诱导的RNA超编辑促进卵巢癌恶性进展的作用和机制
-
批准号:82472792
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2024
-
负责人:刘招舰
-
依托单位:
剪接因子USP39通过调控HMGA2促进卵巢癌侵袭转移的机制
-
批准号:81972437
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:刘招舰
-
依托单位:
长链非编码RNA-PVT1促进浆液性卵巢癌恶性行为的作用和机制
-
批准号:81472432
-
项目类别:面上项目
-
资助金额:72.0万元
-
批准年份:2014
-
负责人:刘招舰
-
依托单位:
miR-182和miR-17家族在输卵管来源高度恶性浆液性癌发生发展过程中的作用和机制
-
批准号:81171897
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:刘招舰
-
依托单位:
国内基金
海外基金